These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29528551)

  • 1. Prevalence of appropriate colorectal cancer screening and preferences for receiving screening advice among people attending outpatient clinics.
    Dodd N; Mansfield E; Carey M; Oldmeadow C
    Aust N Z J Public Health; 2018 Aug; 42(4):334-339. PubMed ID: 29528551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing the effectiveness of a general practice intervention to improve uptake of colorectal cancer screening: a randomised controlled trial.
    Dodd N; Carey M; Mansfield E; Oldmeadow C; Evans TJ
    Aust N Z J Public Health; 2019 Oct; 43(5):464-469. PubMed ID: 31268211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of FOB testing in eastern-Australian general practice patients: what has a national bowel cancer screening program delivered?
    Paul CL; Carey ML; Russell G; D'Este C; Sanson-Fisher RW; Zwar N
    Health Promot J Austr; 2015 Apr; 26(1):39-44. PubMed ID: 25818504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
    Todorov K; Wilson C; Sharplin G; Corsini N
    Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population characteristics related to colorectal cancer testing in New South Wales, Australia: results from the 45 and Up Study cohort.
    Weber MF; Banks E; Ward R; Sitas F
    J Med Screen; 2008; 15(3):137-42. PubMed ID: 18927096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening.
    DeBourcy AC; Lichtenberger S; Felton S; Butterfield KT; Ahnen DJ; Denberg TD
    J Gen Intern Med; 2008 Feb; 23(2):169-74. PubMed ID: 18157581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates and correlates of potentially inappropriate colorectal cancer screening in the Veterans Health Administration.
    Powell AA; Saini SD; Breitenstein MK; Noorbaloochi S; Cutting A; Fisher DA; Bloomfield HE; Halek K; Partin MR
    J Gen Intern Med; 2015 Jun; 30(6):732-41. PubMed ID: 25605531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.
    Almog R; Ezra G; Lavi I; Rennert G; Hagoel L
    Eur J Cancer Prev; 2008 Oct; 17(5):430-7. PubMed ID: 18714185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer screening: what do women from diverse ethnic groups want?
    Walsh JM; Kim SE; Sawaya G; Kaplan CP; Wong ST; Gregorich SE; Pérez-Stable EJ
    J Gen Intern Med; 2013 Feb; 28(2):239-46. PubMed ID: 22968796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-perceived Mental Health Status and Uptake of Fecal Occult Blood Test for Colorectal Cancer Screening in Canada: A Cross-Sectional Study.
    Hategekimana C; Karamouzian M
    Int J Health Policy Manag; 2016 Feb; 5(6):365-71. PubMed ID: 27285514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' Preferences for Primary Colorectal Cancer Screening: A Survey of the National Colorectal Cancer Screening Program in Korea.
    Cho YH; Kim DH; Cha JM; Jeen YT; Moon JS; Kim JO; Lee SK; Cho YK; Im JP; Jang JY; Shin JE; Yoon SM; Jung Y; Kim ES; Lee KN; Cho SJ; Kim Y; Park BY
    Gut Liver; 2017 Nov; 11(6):821-827. PubMed ID: 28750489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
    Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
    World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential screening benefit of a colorectal imaging capsule that does not require bowel preparation.
    Chatrath H; Rex DK
    J Clin Gastroenterol; 2014 Jan; 48(1):52-4. PubMed ID: 23632347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer screening in Australia: a community-level perspective.
    Courtney RJ; Paul CL; Sanson-Fisher RW; Macrae FA; Carey ML; Attia JR; McEvoy MA
    Med J Aust; 2012 May; 196(8):516-20. PubMed ID: 22571309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferences for colorectal cancer screening strategies: a discrete choice experiment.
    Hol L; de Bekker-Grob EW; van Dam L; Donkers B; Kuipers EJ; Habbema JD; Steyerberg EW; van Leerdam ME; Essink-Bot ML
    Br J Cancer; 2010 Mar; 102(6):972-80. PubMed ID: 20197766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing colonoscopy behaviour among Koreans with a positive faecal occult blood tests.
    Choi E; Jeon J; Kim J
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e13008. PubMed ID: 30748048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rethinking the Re-Prep: Attitudes Toward Noninvasive Colorectal Cancer Screening Tests After Inadequate Bowel Preparation.
    Platt KD; Kurlander JE; Zikmund-Fisher BJ; Lipson R; Knaus M; Waljee AK; Saini SD
    Am J Gastroenterol; 2019 Oct; 114(10):1685-1687. PubMed ID: 31464741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of a colorectal cancer screening blood test in people with elevated risk for cancer who cannot or will not complete a faecal occult blood test.
    Symonds EL; Cock C; Meng R; Cole SR; Fraser RJL; Young GP
    Eur J Cancer Prev; 2018 Sep; 27(5):425-432. PubMed ID: 28368949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.